Cyclopharm Secures Three-Year Deal With University of Pennsylvania Health System

MT Newswires Live
03/23

Cyclopharm (ASX:CYC) secured an agreement with the University of Pennsylvania Health System (UPHS) for its Technegas technology, covering 11 clinical locations across Pennsylvania and New Jersey for an initial three-year term, according to a Monday filing with the Australian bourse.

The agreement provides for two Technegas installations at the Hospital of the University of Pennsylvania and at the Perelman Center for Advanced Medicine, as well as contracted installations across a further nine sites in the UPHS network over time, the filing said.

The agreement also allows for the potential of expanding beyond the initially contracted 11 locations to additional sites affiliated with UPHS, per the filing.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10